Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Breast Cancer Research and Treatment
Published in: Breast Cancer Research and Treatment 1/1999

01-01-1999

The methodology of quantitation of microvessel density and prognostic value of neovascularization associated with long‐term survival in Japanese patients with breast cancer

Authors: Takao Kato, Tsunehito Kimura, Nobue Ishii, Akiho Fujii, Kazuko Yamamoto, Shingo Kameoka, Toshio Nishikawa, Takeshi Kasajima

Published in: Breast Cancer Research and Treatment | Issue 1/1999

Login to get access
Metadata
Title
The methodology of quantitation of microvessel density and prognostic value of neovascularization associated with long‐term survival in Japanese patients with breast cancer
Authors
Takao Kato
Tsunehito Kimura
Nobue Ishii
Akiho Fujii
Kazuko Yamamoto
Shingo Kameoka
Toshio Nishikawa
Takeshi Kasajima
Publication date
01-01-1999
Publisher
Kluwer Academic Publishers
Published in
Breast Cancer Research and Treatment / Issue 1/1999
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1023/A:1006193024382

Other articles of this Issue 1/1999

Breast Cancer Research and Treatment 1/1999 Go to the issue

OriginalPaper

Course Announcement — Critical issues in tumor microcirculation, angiogenesis and metastasis: biological significance and clinical relevance — Thirteenth Annual Offering June 7-10, 1999, A Continuing Education Course, Harvard Medical School and Massachusetts General Hospital, Boston, MA

OriginalPaper

Applying the Nottingham Prognostic Index to a Swedish breast cancer population

OriginalPaper

Instructions for authors

OriginalPaper

Loss of heterozygosity in BRCA1 and BRCA2 markers and high‐grade malignancy in breast cancer

OriginalPaper

Male breast cancer in the hereditary nonpolyposis colorectal cancer syndrome

OriginalPaper

Antisense oligonucleotides to the epidermal growth factor receptor
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits